Aerpio Therapeutics, Inc. announced the appointment of Adrienne Graves, Ph.D., to its board of directors. Dr. Graves previously served as President and Chief Executive Officer and Vice President of Worldwide Clinical Development of Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co. Ltd., where she served as a Corporate Officer.